EBV DNA: a Hodgkin lymphoma biomarker?
Blood
; 121(18): 3541-2, 2013 May 02.
Article
em En
| MEDLINE
| ID: mdl-23640993
ABSTRACT
In this issue of Blood, Kanakry and colleagues report that increased pretreatment levels of plasma Epstein Barr virus DNA (EBV-DNA), as determined by quantitative real-time polymerase chain reaction (QRT-PCR), are associated with inferior outcomes among patients with previously untreated, advanced-stage Hodgkin lymphoma.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
DNA Viral
/
Doença de Hodgkin
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Herpesvirus Humano 4
/
Infecções por Vírus Epstein-Barr
Limite:
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article